Astrana Health Inc (ASTH)
37.15
-0.78
(-2.06%)
USD |
NASDAQ |
Apr 30, 16:00
37.19
+0.04
(+0.11%)
After-Hours: 20:00
Astrana Health Cash from Financing (TTM): 3.421M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.421M |
| September 30, 2023 | -2.701M |
| June 30, 2023 | -8.442M |
| March 31, 2023 | -27.72M |
| December 31, 2022 | -20.08M |
| September 30, 2022 | -24.52M |
| June 30, 2022 | -29.29M |
| March 31, 2022 | -48.48M |
| December 31, 2021 | -47.75M |
| September 30, 2021 | -48.54M |
| June 30, 2021 | -59.32M |
| March 31, 2021 | -38.37M |
| December 31, 2020 | -51.70M |
| September 30, 2020 | -62.72M |
| June 30, 2020 | 111.15M |
| March 31, 2020 | 161.08M |
| December 31, 2019 | 163.33M |
| September 30, 2019 | 167.90M |
| June 30, 2019 | 12.19M |
| March 31, 2019 | -20.74M |
| December 31, 2018 | -11.18M |
| September 30, 2018 | -5.288M |
| June 30, 2018 | -1.684M |
| March 31, 2018 | 9.314M |
| September 30, 2017 | 9.838M |
| Date | Value |
|---|---|
| June 30, 2017 | 9.218M |
| March 31, 2017 | 8.925M |
| December 31, 2016 | 4.134M |
| September 30, 2016 | 6.194M |
| June 30, 2016 | 6.607M |
| March 31, 2016 | 6.342M |
| December 31, 2015 | 1.138M |
| September 30, 2015 | -0.2668M |
| June 30, 2015 | 1.235M |
| March 31, 2015 | 1.655M |
| December 31, 2014 | 3.290M |
| September 30, 2014 | 2.844M |
| June 30, 2014 | 1.462M |
| January 31, 2014 | 2.026M |
| October 31, 2013 | 1.789M |
| July 31, 2013 | 1.202M |
| April 30, 2013 | 1.205M |
| January 31, 2013 | 0.9861M |
| October 31, 2012 | 0.075M |
| July 31, 2012 | 0.1657M |
| April 30, 2012 | 0.1657M |
| January 31, 2012 | -0.0043M |
| October 31, 2011 | -0.0069M |
| July 31, 2011 | -0.0027M |
| April 30, 2011 | -0.0024M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-62.72M
Minimum
Sep 2020
167.90M
Maximum
Sep 2019
7.866M
Average
-24.52M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
| American Shared Hospital Services | 1.91M |
| Novo Integrated Sciences Inc | 4.668M |
| Cryo-Cell International Inc | -0.7611M |
| P3 Health Partners Inc | 100.33M |
| Biote Corp | -14.38M |